Novartis Pharmaceuticals Corporation v. Mylan Pharmaceuticals Inc. et al > Summary
Court Case Number 1:21-cv-00146
Filing Date Dec 20, 2021
Termination Date Apr 5, 2022
Court West Virginia Northern District Court
Status Transfer/Remand - MDL Transfer
JudgesThomas S. Kleeh
Plaintiff
Defendant
Plaintiff Attorneys
6Novartis
Attorney Name: Nicholas N. Kallas
Venable
Novartis
Attorney Name: Sandra K. Law
Schrader Companion Duff & Law, PLLC
Novartis
Attorney Name: Christopher E. Loh
Venable
Novartis
Attorney Name: Christina A. Schwarz
Venable
Novartis
Attorney Name: Jared L. Stringham
Venable
Defendant Attorneys
3Viatris Inc.
Attorney Name: Gordon H. Copland
Steptoe & Johnson PLLC
Viatris Inc.
Attorney Name: William J. O'Brien
Steptoe & Johnson PLLC
Viatris Inc.
Attorney Name: Robert L. Florence
Parker Poe Adams & Bernstein LLP
Counter Defendant
6Novartis
Attorney Name: Nicholas N. Kallas
Venable
Novartis
Attorney Name: Sandra K. Law
Schrader Companion Duff & Law, PLLC
Novartis
Attorney Name: Christopher E. Loh
Venable
Novartis
Attorney Name: Christina A. Schwarz
Venable
Novartis
Attorney Name: Jared L. Stringham
Venable
Counter Claimant
3Viatris Inc.
Attorney Name: Gordon H. Copland
Steptoe & Johnson PLLC
Viatris Inc.
Attorney Name: Robert L. Florence
Parker Poe Adams & Bernstein LLP
Viatris Inc.
Attorney Name: William J. O'Brien
Steptoe & Johnson PLLC
Cause
35:271 Patent Infringement
Related Patents
| Doc No | Title | Issue date |
|---|---|---|
| 11058667 | Sacubitril-valsartan dosage regimen for treating heart failure | Jul 13, 2021 |
